ID

20821

Beschrijving

This study is a prospective, interventional, open-label, multi-center early access program for the use of Ra-223 Cl2 in HRPC/CRPC (Hormone refractory prostate cancer / Castrate resistant prostate cancer) patients diagnosed with bone metastasis and to collect additional short and long term safety data on the product. NCT01618370

Trefwoorden

Versies (1)
  1. 20-03-17 20-03-17 -
Geüploaded op

20 maart 2017

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY-NC 3.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Radium-223 Dichloride (Alpharadin) DRKS00006460 NCT01618370 in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases (End of Study Treatment)

Engels

Radium 223 Dichloride (Alpharadin) - End of Study Treatment

1 Formulieren  
End of Study Treatment
Beschrijving

End of Study Treatment

Did the subject complete the treatment period?
Beschrijving

treatment period completed

Datatype

boolean

Alias
UMLS CUI [1]
C2732579
Primary reason for discontinuation of study treatment
Beschrijving

Primary reason for discontinuation of study treatment

Datatype

text

Alias
UMLS CUI [1,1]
C0008976
UMLS CUI [1,2]
C0457454
UMLS CUI [1,3]
C1549995
If primary reason is "Adverse Event(s) not associated with clinical disease progression", give number(s). Up to 3 AE numbers can be entered:
Beschrijving

Dynamic search /ist contains: "Number - Term - Start Date"

Datatype

text

Alias
UMLS CUI [1,1]
C1444662
UMLS CUI [1,2]
C0392360
UMLS CUI [1,3]
C0877248
If primary reason is "Withdrawal by subject (Consent withdrawn)",specify
Beschrijving

primary reason Consent withdrawn

Datatype

text

Alias
UMLS CUI [1,1]
C1549995
UMLS CUI [1,2]
C1707492
If primary reason is "Other",specify
Beschrijving

If primary reason is "Other",specify

Datatype

text

Alias
UMLS CUI [1,1]
C1549995
UMLS CUI [1,2]
C0205394
Subject entered active follow-up?
Beschrijving

Subject entered active follow-up?

Datatype

text

Alias
UMLS CUI [1]
C0589120
Terug naar het begin van de pagina

Similar models

Radium 223 Dichloride (Alpharadin) - End of Study Treatment

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
End of Study Treatment
treatment period completed
Item
Did the subject complete the treatment period?
boolean
C2732579 (UMLS CUI [1])
Primary reason for discontinuation of study treatment
Item
Primary reason for discontinuation of study treatment
text
C0008976 (UMLS CUI [1,1])
C0457454 (UMLS CUI [1,2])
C1549995 (UMLS CUI [1,3])
primary reason Adverse Event
Item
If primary reason is "Adverse Event(s) not associated with clinical disease progression", give number(s). Up to 3 AE numbers can be entered:
text
C1444662 (UMLS CUI [1,1])
C0392360 (UMLS CUI [1,2])
C0877248 (UMLS CUI [1,3])
primary reason Consent withdrawn
Item
If primary reason is "Withdrawal by subject (Consent withdrawn)",specify
text
C1549995 (UMLS CUI [1,1])
C1707492 (UMLS CUI [1,2])
If primary reason is "Other",specify
Item
If primary reason is "Other",specify
text
C1549995 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
Subject entered active follow-up?
Item
Subject entered active follow-up?
text
C0589120 (UMLS CUI [1])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial